
Bortirel 3.5mg Injection
Marketer
Reliance Life Sciences
Salt Composition
Bortezomib (3.5mg)
Overview Bortirel 3.5mg Injection
Axitinib 3.5mg Injection is indicated for managing multiple myeloma and mantle cell lymphoma. Its mechanism of action involves inhibiting or decelerating the proliferation of cancerous cells. Administration of Axitinib 3.5mg Injection is strictly via intravenous injection by a healthcare professional. Dosage frequency and regimen are determined by your physician based on your specific condition and may be adjusted. Adhere precisely to your doctor's prescribed regimen. Incorrect usage or overdose may lead to severe adverse events. Therapeutic effects might not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include fatigue, nausea, emesis, and anorexia. Increased daily fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can reduce blood cell counts (including red and white blood cells), raising infection risk. Regular blood tests to monitor blood cell counts, along with liver, cardiac, and uric acid levels are necessary. Prior to commencing Axitinib 3.5mg Injection, disclose any pre-existing liver, kidney, cardiac, or bleeding disorders to your physician. Report any cognitive impairment, such as memory loss or difficulty concentrating, immediately. Inform your healthcare provider about all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception is essential for both partners during treatment to prevent conception.
Uses of Bortirel 3.5mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Bortirel 3.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Bortirel 3.5mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Bortirel 3.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Bortirel 3.5mg Injection works:
Bortirel 3.5mg Injection is an anticancer agent that inhibits the cellular degradation of proteins. This protein accumulation within cancerous cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Bortirel 3.5mg Injection and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Bortirel 3.5mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice before use.
Breast feedingUNSAFE
Administering Bortirel 3.5mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Bortirel 3.5mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially impairing driving ability.
KidneyCAUTION
Caution is advised when administering Bortirel 3.5mg Injection to individuals with advanced renal impairment. The prescribed dosage of Bortirel 3.5mg Injection might require modification. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Bortirel 3.5mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bortirel 3.5mg Injection :
Should you inadvertently skip a dose of Bortirel 3.5mg Injection, seek advice from your physician.
Facts to Know About Bortirel 3.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
